Full Text
PCN101 Cost Effectiveness of Everolimus for Second Line Treatment of Metastatic Renal Cell Cancer in Serbia

Abstract

Authors

J. Mihajlović P. Pechlivanoglou A. Sabo Z. Tomić M.J. Postma

Back to Volume 15, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×